Form 4 Tracker
Barbara-Jean Anne Bormann-Kennedy

Director · 1 filing · Latest: Jun 4, 2026

Xeris Biopharma Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
XERS
Barbara-Jean Anne Bormann-KennedyDirectorJun 4, 2026
Sale
$6.0916,000$97.5K126,500